Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Atea Pharmaceuticals Inc AVIR

Healthcare Biotechnology
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). It has a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AVIR)

Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference

GlobeNewswire November 19, 2025

Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 12, 2025

Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025

GlobeNewswire November 7, 2025

Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025

GlobeNewswire November 5, 2025

Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025

GlobeNewswire October 22, 2025

Atea Pharmaceuticals to Present New Data Supporting Combination of Bemnifosbuvir and Ruzasvir as Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025

GlobeNewswire October 7, 2025

Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

GlobeNewswire September 2, 2025

Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire August 7, 2025

Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025

GlobeNewswire July 31, 2025
View More News ››

Opinion & Analysis (NDAQ:AVIR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AVIR)

6 REASONS TO AVOID ATEA PHARMACEUTICALS ($AVIR)

6 REASONS TO AVOID ATEA PHARMACEUTICALS ($AVIR) https://www.aviseanalytics.com/6-reasons-to-avoid-atea-pharmaceuticals/ Atea...
AviseAnalytics - November 19, 2021

AVIR - Friday Rundown, Monday Expectations

<< View Post To Watch Video >>
HDavis - October 31, 2021

RE:Bonvoyage12....Pathetic Pumper

India's Ivermectin Blackout - Part V: The Secret Revealed ...   Sep 27, 2021 · By September 12, 2021...
zeropointenergy - October 6, 2021

Bonvoyage12....Pathetic Pumper

This pumper spams multiple boards with paid PR BS......depserately trying to promote losing stocks....ignore him and report him.
Mil_Man54 - December 1, 2020
View more Bullboard ››

Mullen Group Ltd

Mullen Group Ltd

Mullen Group Ltd. provides a range of trucking and logistics services in Canada and the United States. It operates through ...
View More »